You Are Browsing ‘Medical’ Category

Semler Scientific Inc (NASDAQ:SMLR) intends to report and discuss its 4Q and fiscal 2014 earnings results on February 6. Analysts expect SMLR to post losses for both periods. However, the company is cited as having a powerful marketing strategy for its only product known as FloChec. Investors have been betting…

Nano cap stock, Venaxis Inc (NASDAQ:APPY) was crushed heavily in the last trading session after an unsuccessful APPY1 result leading to the Food And Drug…

It’s been a good start to the year for CorMedix Inc. (NYSEMKT:CRMD), which has now earned a Qualified Infectious Disease Product (QIDP) designation…

Genetic Technologies Limited (ADR) (NASDAQ:GENE) roared and ruled on the stock exchange after announcing that new six breast cancer treatment centers will…

Pluristem Therapeutics Inc. (NASDAQ:PSTI) soared in the market by double percentage gains after equity research firm Acceleron echoed bullish sentiments on the company. The research firm on a research note to investors upgraded the stock to a ‘Buy’ with a share price target of $21. The research firm maintains that Pluristem Therapeutics stock should trade at a 745%…

Aldeyra Therapeutics Inc. (NASDAQ:ALDX) has confirmed its participation in the upcoming Canaccord Genuity Rare Disease conference that is to take place…

Apricus Biosciences Inc (NASDAQ:APRI), a micro cap stock, jumped by as much as 9.02% to close at $1.33 in the previous trading session. The rally continued…

ABIOMED, Inc. (NASDAQ:ABMD) gave a sweet surprise to its investors with not just robust third-quarter results but also a new heart device. The positive…

Pfizer Inc. (NYSE:PFE)‘s fourth quarter earnings were clouded by the aftereffects of the strong U.S. Dollar and its drug patent loss. The company…

American Green Inc. (OTCMKTS:ERBB) finally unveiled the much awaited vending machine ZaZZZ to little fanfare, much to the concern of investors as the same…

SPYR banner1